Filing Details
- Accession Number:
- 0001225208-25-001817
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-18 16:14:16
- Reporting Period:
- 2025-02-13
- Filing Date:
- 2025-02-18
- Accepted Time:
- 2025-02-18 16:14:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 33185 | Equifax Inc | EFX | Services-Consumer Credit Reporting, Collection Agencies (7320) | 580401110 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1335111 | W Mark Begor | 1550 Peachtree Street, N.w. Atlanta GA 30309 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-13 | 22,161 | $175.48 | 164,404 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-13 | 595 | $253.60 | 163,809 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 1,402 | $256.31 | 162,407 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 1,600 | $252.38 | 160,807 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 5,214 | $255.27 | 155,593 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 6,199 | $250.74 | 149,394 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 7,151 | $251.60 | 142,243 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option/Right to Buy | Disposition | 2025-02-13 | 22,161 | $0.00 | 22,161 | $175.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 22,160 | 2026-02-21 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 43,382 | Indirect | 2-Year 2023 GRAT |
| Common Stock | 20,025 | Indirect | 2-year Feb 2024 GRAT |
| Common Stock | 24,125 | Indirect | 2-yr Jul 2024 GRAT |
| Common Stock | 24,225 | Indirect | 3-yr Jul 2024 GRAT |
| Common Stock | 12,333 | Indirect | 4-Year 2021 GRAT |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024.
- Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 147 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
- The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $253.26 to $254.19, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $255.89 to $256.78, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $252.24 to $252.61, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $254.815 to $255.77, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $250.095 to $251.03, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $251.17 to $252.14, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- The option vested in three equal annual increments beginning 2/21/2021.
Billionaire Hedge Funds
